Lion Biotechnologies, Inc. Appoints Dr. Laszlo Radvanyi As Chief Scientific Officer
6/23/2014 7:56:00 AM
LOS ANGELES, June 23, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCQB:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes (TILs), today announced that it has appointed Laszlo Radvanyi, PhD, as its chief scientific officer (CSO).
Help employers find you! Check out all the jobs and post your resume.
comments powered by